FTI-277 trifluoroacetate salt
SIGMA/F9803 - ≥95% (HPLC), film
Synonym: N-
CAS Number: 170006-73-2 (free base)
Empirical Formula (Hill Notation): C22H29N3O3S2 · xC2HF3O2
Molecular Weight: 447.61 (free base basis)
MDL Number: MFCD06795840
Linear Formula: C22H29N3O3S2 · xC2HF3O2
Product Type: Chemical
| assay | ≥95% (HPLC) |
| form | film |
| InChI | 1S/C22H29N3O3S2.C2HF3O2/c |
| InChI key | GJEFFRDWFVSCOJ-PXPMWPIZSA |
| Quality Level | 100 ![]() |
| shipped in | dry ice |
| SMILES string | OC(=O)C(F)(F)F.COC(=O)[C@ |
| solubility | H2O: ≥2 mg/mL |
| storage condition | desiccated |
| storage temp. | −70°C |
| Application: | Farnesyltransferase inhibitor 277 (FTI-277) has been used to: • inhibit protein farnesylation in breast cell lines. • in marrow-isolated adult multilineage inducible cells (MIAMI). • inhibition of farnesyl transferase in CV-1 in Origin with SV40 genes cells (COS-7). |
| Biochem/physiol Actions: | Farnesyltransferase inhibitor 277 (FTI-277) mediates apoptosis in multiple myeloma and is regarded as a potential therapeutic agent. |
| Biochem/physiol Actions: | Highly potent (pM/nM) Ras CAAX peptidomimetic which antagonizes both H and K-Ras oncogenic signaling. Inhibitor of farnesyltransferase (Ftase) IC50 = 50 nM. |
| Packaging: | 1, 5 mg in glass bottle |
| Packaging: | Very hygroscopic material, package in a dry room with deoxygenated MeOH and pump down the solvent. Store with desiccant. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | −70°C |
| UNSPSC | 51111800 |


